Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers
Open Access
- 16 March 2017
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 18 (1) , 1-10
Abstract
Agricultural environments are contaminated with organic dusts containing bacterial components. Chronic inhalation of organic dusts is implicated in respiratory diseases. CD14 is a critical receptor for gram-negative lipopolysaccharide; however, its association with respiratory disease among agricultural workers is unknown. The objective of this study was to determine if serum soluble CD14 (sCD14) levels are associated with lung function among agricultural workers and if this association is modified by genetic variants in CD14. This cross-sectional study included 584 veterans with >2 years of farming experience and that were between the ages of 40 and 80 years. Participants underwent spirometry and were genotyped for four tagging CD14 polymorphisms (CD14/-2838, rs2569193; CD14/-1720, rs2915863; CD14/-651, rs5744455; and CD14/-260, rs2569190). Serum sCD14 was assayed by ELISA. Subjects were 98% white males with a mean age 64.5 years. High soluble CD14 levels (> median sCD14) were associated decreased lung function (FEV1/FVC, p = 0.011; % predicted FEV1, p = 0.03). When stratified by COPD (yes/no) and smoking status (ever/never), high sCD14 levels (> median sCD14) were associated with low lung function among ever smokers with COPD (% predicted FEV1, padj = 0.0008; FEV1/FVC, padj = 0.0002). A similar trend was observed for never smokers with COPD; however, results did not reach statistical significance due to small sample size. There was a significant sCD14 x COPD/smoking interaction with lung function (% predicted FEV1, pinter = 0.0498; FEV1/FVC, pinter = 0.011). Regression models were adjusted for age, body mass index, education, sex, race and years worked on a farm. No association was found between CD14 polymorphisms/haplotypes (CD14/-2838; CD14/-1720; CD14/-651; CD14/-260) and sCD14 levels. The final model included the variables sCD14 and haplotypes and a haplotype x sCD14 interaction term. Individuals with the GTTG haplotype (CD14/-2838 → CD14/-260) and high sCD14 levels (> median sCD14) had on average 6.94 lower % predicted FEV1 than individuals with the GCCA haplotype and low sCD14 levels (≤ median sCD14, padj = 0.03). CD14 haplotypes and sCD14 are important mediators of lung function among those with COPD in this occupationally-exposed population.Keywords
Funding Information
- VA Merit Award (1I01CX000434, not assigned)
This publication has 44 references indexed in Scilit:
- Association between CD14 Promoter -159C/T Polymorphism and the Risk of Sepsis and Mortality: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Association of CD14 -260 (-159) C>Tand asthma: a systematic review and meta-analysisBMC Medical Genetics, 2011
- Gene-environment interactions influence airways function in laboratory animal workersJournal of Allergy and Clinical Immunology, 2010
- Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challengeInhalation Toxicology, 2010
- Role of CD14 in lung inflammation and infectionCritical Care, 2010
- Influence of C-159T SNP of the CD14 gene promoter on lung function in smokersRespiratory Medicine, 2009
- Association between CD14 polymorphisms and serum soluble CD14 levels: Effect of atopy and endotoxin inhalationJournal of Allergy and Clinical Immunology, 2008
- CD14 promoter polymorphisms have no functional significance and are not associated with atopic phenotypesPharmacogenetics and Genomics, 2006
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- The immune system evolved to discriminate infectious nonself from noninfectious selfImmunology Today, 1992